Dr. Reddy’s Laboratories Ltd. All rights reserved.
Dr Reddy Labs(REDYc2:NS)股票历史数据一览,包括Dr Reddy Labs(REDYc2:NS)股票历史行情,每日股价和涨跌走势图表。
E. Kumar Sharma
Dr. Reddy's is notifying its distributors and customers to arrange for return of any recalled product. Wholesalers, distributors, hospitals, and pharmacies with an existing inventory of the impacted lot are asked to stop use and distribution and quarantine the product immediately for return/replacemen...
Dr. Reddy´s Labs (BSE) 最新股价 1,117.65 更改% 0.00 添加到投资组合 添加到观察表 添加到预警 最近的10笔交易 INR 时间 最新股价 成交量(股) 显示时间以您在 Euroland.com 选择的时区为准 刷新 报价 INR 时间 2/28/2025 最新股价 1,117.65 更改% 0.00 更改 0.00 买入价...
Dr Reddy's Laboratories Ltd announced the launch of the US Food and Drug Administration (FDA) approved icosapent ethyl capsules, 1 gram Dr Reddy's icosapent ethyl capsules, 1 gram is approved for the indication of as an adjunct to diet to reduce triglyceride (TG) levels in adult patients wi...
Dr Reddy's Laboratories is expecting its business growth to be "volatile" in the current fiscal, the company said in its Annual Report for 2020-21. "The last few months have seen a second wave of Covid-19 impacting several parts of the world, and the most in India. While vaccinations ...
Dr. Reddy's Labs Rating 'Hold'; A steady Q3FY22 for the pharma company Click Here for the Complete Story [PDF Format] DRL Q3 Results: Drugmaker posts 25 times rise in PAT at Rs 709 cr, in line with estimates Click Here for the Complete Story [PDF Format] ...
Dr Reddy's labs is very good company and we can learn all the things related to entire pharma. GMP and manufacturing, advanced Technologies and Good infrastructure, Very good work culture.. Dr Reddy's is simply awesome...Show more July 14, 2019 Culture Scientist Hyderabad, Telangana Best w...
Dr Reddy’s Laboratories的养老金计划资产总额于March 2021触及5年低点,是2.166十亿。 Dr Reddy’s Laboratories的养老金计划资产总额于2021 (2.166十亿, -5.3%)减少和于2020 (2.288十亿, +2.0%)、2022 (2.565十亿, +18.4%)、2023 (3.341十亿, +30.3%)和2024 (3.395十亿, +1.6%)增加。